ArticleNature communications2022

Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.

Yexuan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.